Variable Clinical Presentation of Shwachman–Diamond Syndrome: Update from the North American Shwachman–Diamond Syndrome Registry - 19/03/14
Abstract |
Objectives |
To investigate the range of clinical presentations for Shwachman–Diamond syndrome (SDS) with the long-term goal of improving diagnosis.
Study design |
We reviewed the North American Shwachman–Diamond Syndrome Registry. Genetic reports of biallelic Shwachman–Bodian–Diamond syndrome mutations confirming the diagnosis of SDS were available for 37 patients.
Results |
Neutropenia was the most common hematologic abnormality at presentation (30/37, 81%); however, only 51% (19/37) of patients presented with the classic combination of neutropenia and steatorrhea. Absence of pancreatic lipomatosis on ultrasound or computed tomography scan, normal fecal elastase levels, and normal skeletal survey do not rule out the diagnosis of SDS. SDS was diagnosed in 2 asymptomatic siblings of SDS probands. Twenty-four of 37 patients (65%) had congenital anomalies.
Conclusion |
Our cohort reveals a broad range of clinical presentation for SDS. Clues to the underlying diagnosis of SDS included cytopenias with a hypocellular marrow, congenital anomalies, family history, and myelodysplasia with clonal abnormalities frequently found in SDS. Reliance on classic clinical criteria for SDS would miss or delay diagnosis of a significant subset of patients with SDS.
Le texte complet de cet article est disponible en PDF.Keyword : AML, CT, MDS, SBDS, SDS, SDSR
Plan
| Supported by the National Institute of Allergy and Infectious Diseases (NIAID; 1 R03 AI079734-02 to A.S.), National Heart, Lung, and Blood Institute (5 R01 HL079582-11 to A.S.), NIAID (5 R24 AI049363-09 to D.D.), Shwachman–Diamond Project Ltd, Shwachman–Diamond Syndrome Foundation, Shwachman–Diamond Syndrome America, The Butterfly Guild at Seattle Children's Hospital, and family donors. The authors declare no conflicts of interest. |
Vol 164 - N° 4
P. 866-870 - avril 2014 Retour au numéro
Article précédent
- 25-Hydroxyvitamin D Concentrations in Children with Crohn's Disease Supplemented with Either 2000 or 400 IU Daily for 6 Months: A Randomized Controlled Study
- Kirstin E. Wingate, Kevan Jacobson, Robert Issenman, Matthew Carroll, Collin Barker, David Israel, Herbert Brill, Hope Weiler, Susan I. Barr, Wangyang Li, Michael R. Lyon, Timothy J. Green
- A Community Cross-Sectional Survey of Medical Problems in 440 Children with Down Syndrome in New York State
- Nancy J. Roizen, Caroline I. Magyar, Emily S. Kuschner, Steven B. Sulkes, Charlotte Druschel, Edwin van Wijngaarden, Lisa Rodgers, Alison Diehl, Richard Lowry, Susan L. Hyman
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?